Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in Women (NCT07507851) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in Women
China312 participantsStarted 2026-04
Plain-language summary
The goal of this clinical trial is to evaluate if electroacupuncture works to prevent recurrent lower urinary tract infections in female patients. It will also learn about the safety of electroacupuncture. The main questions it aims to answer are:
1. Does electroacupuncture reduce the attacks of acute recurrent urinary tract infections in women?
2. What medical problems do participants have when taking electroacupuncture?
Researchers will compare electroacupuncture to sham electroacupuncture to assess if electroacupuncture works to prevent recurrent lower urinary tract infections.
Participants will:
1. Take electroacupuncture or sham electroacupuncture for 30 minutes per session over a 6-month period. During the first month, treatment was administered 3 times weekly (once every other day); the second month, 2 times weekly (once every 2-3 days); and the 3-6 month, once monthly.
2. Visit the hospital at the end of the 1st, 2nd, 3rd, and 6th months for follow-up evaluations.
3. Keep a diary of their symptoms and the number of times they use an antibiotic.
Who can participate
Age range
18 Years – 75 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Female patients aged 18-75 years;
. Meeting the diagnostic criteria for recurrent lower urinary tract infections;
. No acute lower urinary tract infections at enrollment;
. Voluntary participation in this trial and signed informed consent. Only patients who meet all the above inclusion criteria can be enrolled in the study.
Exclusion criteria
. Currently receiving prophylactic antibiotics for lower urinary tract infection;
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of participants with no acute lower urinary tract infection
Timeframe: At the end of the post-randomization 6-month
. Complicated or neurogenic genitourinary disorders, such as spinal cord injury, cauda equina injury, active pelvic inflammatory disease, active vaginitis, overactive bladder, interstitial cystitis;
. Requiring urinary catheterization;
. HIV infection, long-term use of immunosuppressants, infection with multidrug-resistant organisms, or uncontrolled diabetes mellitus;
. Pelvic organ prolapses of grade 2 or above;
. Post-void residual urine volume \> 100 ml measured by B-ultrasound;
. Lactating, pregnant, or planning to conceive within the next 6 months;